Medical surveillance for healthcare workers exposed to hazardous drugs (supersedes 2007-117).
McDiarmid-M; Polovich-M; Power-L; Connor-TH; Weissman-D
Cincinnati, OH: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2013-103, 2012 Nov; :1-4
Healthcare workers who prepare, administer, or transport hazardous drugs or dispose of hazardous drug waste may face risks to their own health such as skin disorders, reproductive disorders, and possibly cancer. NIOSH recommends that employers establish a medical surveillance program as part of a comprehensive prevention program that also minimizes worker exposure through engineering controls, good work practices, and personal protective equipment (PPE) and provides education about working with hazardous drugs. Medical surveillance involves collecting and interpreting data to detect changes in the health status of working populations potentially exposed to hazardous substances. The elements of a medical surveillance program are used to establish an initial baseline of workers' health and then monitor their future health as it relates to their potential exposure to hazardous agents. This information can be used to identify and correct prevention failures leading to disease. Early identification of health problems can also benefit individual workers.
Health-care; Health-care-personnel; Drugs; Pharmaceuticals; Pharmacy-workers; Nurses; Physicians; Surveillance-programs; Medical-personnel; Medicinal-chemicals; Medical-care
Numbered Publication; Workplace Solutions
NTIS Accession No.
DHHS (NIOSH) Publication No. 2013-103; B20121218C
Healthcare and Social Assistance
National Institute for Occupational Safety and Health